Board of Directors
Top leaders from academia, government, and industry, representing a variety of biotech disciplines, serve on Bio Nebraska’s Board of Directors.
Current Directors
Josh Johnson, Chairman
Director of Biologics Operations, Huvepharma
Ronnie Green, Ph.D.
Chancellor, University of Nebraska-Lincoln
Christopher Kratochvil, M.D.
Associate Vice Chancellor, University of Nebraska Medical Center
Todd Sneller
Sneller Associates
Tyler Martin, M.D.
CEO, Adjuvance Technologies
Gary Madsen, Ph.D.
CEO, ProTransit Nanotherapy
Michael Dixon, Ph.D.
President and CEO, UNeMed Corporation
Kyle Nixon
General Manager, Novozymes
Lyle Middendorf
Sr. VP and Chief Technical Officer, LI-COR Biosciences
Charles Bicak, Ph.D.
Senior Vice Chancellor, University of Nebraska at Kearney
Rachel Hurley
Midwest Government Affairs Manager, Bayer Crop Science
Matthew Kreifels
Vice President of Sales, Streck Inc.
Executive Leadership
Rob Owen
Executive Director
Sasha Forsen
Assistant Director